News

The study was conducted in normal healthy volunteers with serum uric acid above 5mg/dl. The results of this study demonstrated that single doses of up to 600mg of

The Independent Safety Monitoring Board’s (ISMB) decision is based on safety assessments of the first five patients to complete at least 30 days of follow up following treatment

In a three-year research collaboration, Biotica will use its bioengineering technology to produce compounds that are not readily accessible via conventional medicinal chemistry approaches. GlaxoSmithKline (GSK) will apply

In his role as vice president of research and development, Ling manages IBT’s development of new tests in allergy and immunology. He brings with him over 25 years

Under the terms of the collaboration, Bristol-Myers Squibb agreed to pay ZymoGenetics an upfront cash payment of $85 million for the development and commercialization rights to PEG-Interferon lambda,

According to Cytori, the Celution system is a European-approved, cell processing device, which extracts and makes a dose of a patient’s own adipose tissue-derived adult stem and regenerative

EpiCept will direct its resources toward the registration of Ceplene in North America and clinical development programs. When complete, these actions are expected to reduce annual expenses by

Jonathan Rowe, chief operating officer for Gene Express stated, “The partnership between Funakoshi and Gene Express is extremely valuable as Funakoshi has the experience and capability to bring

Mr Valenti was most recently vice president and general manager of surgical devices (US) for Covidien. Prior, he spent 12 years with Johnson & Johnson, serving in a